Global Alpha-lactalbumin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Alpha-lactalbumin is a Alpha-lactalbumin and occurs in the milk of most mammals that constitutes approximately 22% of the proteins in human milk and approximately 3.5% of those in bovine milk. It is an important source of bioactive peptides and essential amino acids, and because of its unique amino acid profile, alpha-lactalbumin has potential for multiple uses.
Market Overview:The latest research study on the global Alpha-lactalbumin market finds that the global Alpha-lactalbumin market reached a value of USD 498.05 million in 2022. It’s expected that the market will achieve USD 824.25 million by 2028, exhibiting a CAGR of 8.76% during the forecast period.
COVID-19's impact on related industries
The main impacts of the rapid outbreak of COVID-19 on alpha-lactalbumin enterprises are as follows: 1. Circulation: the decrease in the speed of customs clearance during the epidemic, the suspension or reduction of flights, and the decrease in the efficiency of other logistics methods will affect the circulation speed of products; 2. Production: the probability of large-scale shutdown and production stoppage is unlikely. However, COVID-19 is still in the rapid outbreak stage, and if the epidemic is further serious, the alpha-lactalbumin plant may be shut down and production may be affected to some extent.
As for the downstream demand, the market impact on alpha-lactalbumin demand is relatively small as the consumption of infant formula has strong rigidity.
Alpha-lactalbumin Market Opportunities and Drivers
Alpha-lactalbumin has been widely used in the infant nutrition, food and beverages, dietary supplements and more. Growth in downstream industries will drive the growth of the market to some extent. Alpha-lactalbumin formulations possess high protein quality, clean flavor profile, high water solubility over a wide pH range (2.0-9.0), and thermal stability that makes them compatible for use in beverages. These properties allow alpha-lactalbumin to be used in a variety of food applications where high quality protein is important, including infant formulas, protein-fortified beverages, lactose-free and low-carbohydrate foods, and medical foods.
The infant formula market has seen strong growth over the past decade. Although human milk is the gold standard for early infant nutrition. The World Health Organization and the American Academy of Pediatrics recommend that infants should be exclusively breastfed for the first 6 months of life. However, this recommendation has not been consistently achieved, with the global average exclusive breastfeeding rate at 43%. At the individual level, maternal and infant health status and infant mothers' knowledge related to breastfeeding have a significant impact on exclusive breastfeeding. At the institutional level, support from health care institutions, families, workplaces and public places had a significant effect on exclusive breastfeeding. At the legal policy level, maternity leave system and marketing promotion of breast milk substitutes had a significant effect on exclusive breastfeeding. Combining these factors, infant formula is an appropriate alternative feeding method. Considering the number of infants receiving mixed feeding (HM and formula) and the importance of early nutrition for optimal growth and development, there is a need for continued research on the composition of infant formula and the health outcomes of formula-fed infants.
Alpha-lactalbumin Market Challenges
Regulatory Compliance
As governments become more stringent in their regulation of food safety and environmental protection, it is especially important to strengthen the management of food safety and environmental concerns, which places higher demands on the development of the alpha-lactalbumin industry, and will increase the responsibility and security investment of companies to promote environmental protection at a high level, manage odors, and prevent food safety risks. In Europe, regulations tend to be very conservative or vague, and this continues to have a negative impact on the market and creates commercial uncertainty. Strict policies may result in suppliers being at a disadvantage to external competitors. This may lead to relocation of firms to other countries.
On the other hand, regulators can also have a positive impact, thereby contributing to the growth of alpha-lactalbumin. The government authorities allowing the use of alpha-lactalbumin in infant formula and sports nutrition products will support the growth of the market. For instance, in 2019, the European Commission approved the use of alpha-lactalbumin as a novel food product to be used in infant formula and food supplements. Lacprodan® ALPHA-10 was approved by the US Food & Drug Administration. The FDA's decision signifies that Lacprodan® ALPHA-10 can be used as an ingredient in milk-based formulas and means that Arla can supply 41% alpha-lactalbumin concentrate to the U.S. infant formula market.
Region Overview:Geographically, Europe held the largest market share – 43.76% in 2022.
Company Overview:The top three companies are Arla Foods Ingredients, Agropur, Lactalis Group with the revenue market share of 39.25%, 23.56%, 9.04% in 2020.
Arla Foods Ingredients
Arla Foods Ingredients is a leading whey ingredient supplier for infant nutrition, baking, dairy, medical applications and sports nutrition. Arla Foods Ingredients Group P/S is a subsidiary of Arla Foods, a global dairy cooperative owned by dairy farmers in six countries.
Arla Foods Ingredients
Agropur manufactures and distributes dairy food and nutrition products. The Company offers milk, cream, cheese, yogurt, butter, ice cream, and other ingredients.
Segmentation Overview:Among different product types, Cattle Alpha-Lactalbumin segment is anticipated to contribute the largest market share in 2028.
Application Overview:By application, the Infant Formulas segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Alpha-lactalbumin market covered in Chapter 3:Lactalis Group
Arla Foods Ingredients
Agropur
Hilmar Ingredients
In Chapter 4 and Chapter 14.2, on the basis of types, the Alpha-lactalbumin market from 2018 to 2029 is primarily split into:Human Alpha-Lactalbumin
Cattle Alpha-Lactalbumin
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Alpha-lactalbumin market from 2018 to 2029 covers:Infant Formulas
Dietary Supplements
Pharmaceuticals
Dairy Products
Food & Beverages
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)